Therapeutical Class：Tetracycline derivative, inhibits bacterial protein synthesis by binding to the 30s subunit on the ribosome and inhibits binding of the aminoacyl-t-RNA molecules

Indication：G(+), G(-), anaerobes (including Clostridia, not for B. fragilis), Chlamydia, Mycoplasma pneumoniae, Rickettsiae.

Administraton：PO.

Adults: 250-500 mg q6h.

Children (>8 yrs): 25-50 mg/kg/day in 4 divided doses.

Adverse Effect：Nausea, vomiting, diarrhea, epigastric burning, photosensitivity, discoloration of teeth.

Contraindication：Children <8yrs.

Pregnancy Risk：D

Supply：Tetracycline HCL Cap 250mg（鹽酸四環素膠囊 榮民）＜00022＞